Abstract

Homocysteine (Hcy) is a sulfur-containing non-proteinogenic amino acid derived in methionine metabolism. The increased level of Hcy in plasma, hyperhomocysteinemia, is considered to be an independent risk factor for cardio and cerebrovascular diseases. However, it is still not clear if Hcy is a marker or a causative agent of diseases. More and more research data suggest that Hcy is an important indicator for overall health status. This review represents the current understanding of molecular mechanism of Hcy metabolism and its link to hyperhomocysteinemia-related pathologies in humans. The aberrant Hcy metabolism could lead to the redox imbalance and oxidative stress resulting in elevated protein, nucleic acid and carbohydrate oxidation and lipoperoxidation, products known to be involved in cytotoxicity. Additionally, we examine the role of Hcy in thiolation of proteins, which results in their molecular and functional modifications. We also highlight the relationship between the imbalance in Hcy metabolism and pathogenesis of diseases, such as cardiovascular diseases, neurological and psychiatric disorders, chronic kidney disease, bone tissue damages, gastrointestinal disorders, cancer, and congenital defects.

Highlights

  • It has been reported that the ratio between SAM/SAH should be used as a biomarker and may provide a sensitive indicator for the clinical diagnosis of atherosclerosis [74]. Another scientific group investigate the effect of elevated Hcy level on fatty acid binding protein 4 (FABP4) [75]. Their results showed that FABP4 has a very important function in lipid metabolism disturbance after Hcy treatment and that DNA methyltransferase 1 (DNMT1; EC 2.1.1.37) could be a potential therapeutic target in Hcy-related atherosclerosis [75]

  • The imbalance in Hcy metabolism is linked with a number of human pathologies

  • It remains unclear whether excessive Hcy concentration directly contributes to the pathogenesis of diseases or it represents a biomarker of metabolic aberrations, such as aberrant methyl group metabolism

Read more

Summary

Homocysteine Metabolism

Homocysteine (Hcy) is a non-essential, sulfur-containing, non-proteinogenic amino acid. The other excessively important enzymatic activity of transsulfuration enzymes (CBS, CSE) is H2 S production from catalysis of Hcy and/or Cys. H2 S is the third gasotransmitter and is produced in different cells and tissues in human body. The central nervous system lacks BHMT, being dependent on folate/vitamin B12-dependent pathway for the conversion of Hcy to Met, which refers brain to higher vulnerability to the increased Hcy levels [16]. Supplementation with natural folate-rich foods, folic acid and folate, vitamins B6 or B12 and the intake of proteins rich in Met and Cys) [22] These dietary nutrients influence the supply of methyl groups and regulate the biochemical pathways for methylation processes. Hcy may act together with the other cellular changes associated with aging in development of cellular dysfunction

Toxicity of Homocysteine
Homocysteine Induces Homocysteinylation
Homocysteine and Oxidative Stress
Homocysteine as a Neurotoxin
Hyperhomocysteinemia and Diseases
Cardiovascular Diseases
Neurological and Psychiatric Disorders
Chronic Kidney Disease
Bone Tissue Damages
Gastrointestinal Disorders
Cancer
Congenital Disorders
Findings
Conclusions and Perspectives
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.